Trials / Sponsors / Orca Biosystems, Inc.
Orca Biosystems, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Le Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia | Phase 2 | 2025-12-09 |
| Active Not Recruiting | Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia | Phase 3 | 2022-06-21 |
| Active Not Recruiting | Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancie Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2019-11-21 |
| Recruiting | A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Acute Myeloid Leukemia, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia | Phase 1 | 2019-04-08 |
| Temporarily Not Available | Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoid Leukemia | — | — |